BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 1379707)

  • 1. The trigemino-vascular system and migraine.
    Buzzi MG; Moskowitz MA
    Pathol Biol (Paris); 1992 Apr; 40(4):313-7. PubMed ID: 1379707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurogenic inflammation in the context of migraine.
    Williamson DJ; Hargreaves RJ
    Microsc Res Tech; 2001 May; 53(3):167-78. PubMed ID: 11301492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for 5-HT1B/1D receptors mediating the antimigraine effect of sumatriptan and dihydroergotamine.
    Buzzi MG; Moskowitz MA
    Cephalalgia; 1991 Sep; 11(4):165-8. PubMed ID: 1660351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blockade of calcitonin gene-related peptide release after superior sagittal sinus stimulation in cat: a comparison of avitriptan and CP122,288.
    Knight YE; Edvinsson L; Goadsby PJ
    Neuropeptides; 1999 Feb; 33(1):41-6. PubMed ID: 10657470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 5-Hydroxytryptamine receptor agonists for the abortive treatment of vascular headaches block mast cell, endothelial and platelet activation within the rat dura mater after trigeminal stimulation.
    Buzzi MG; Dimitriadou V; Theoharides TC; Moskowitz MA
    Brain Res; 1992 Jun; 583(1-2):137-49. PubMed ID: 1324091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional immunohistochemistry of neuropeptides and nitric oxide synthase in the nerve fibers of the supratentorial dura mater in an experimental migraine model.
    Knyihár-Csillik E; Tajti J; Chadaide Z; Csillik B; Vécsei L
    Microsc Res Tech; 2001 May; 53(3):193-211. PubMed ID: 11301495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Further characterization of the putative 5-HT receptor which mediates blockade of neurogenic plasma extravasation in rat dura mater.
    Buzzi MG; Moskowitz MA; Peroutka SJ; Byun B
    Br J Pharmacol; 1991 Jun; 103(2):1421-8. PubMed ID: 1653072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The trigeminovascular system and migraine: studies characterizing cerebrovascular and neuropeptide changes seen in humans and cats.
    Goadsby PJ; Edvinsson L
    Ann Neurol; 1993 Jan; 33(1):48-56. PubMed ID: 8388188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dihydroergotamine and sumatriptan attenuate levels of CGRP in plasma in rat superior sagittal sinus during electrical stimulation of the trigeminal ganglion.
    Buzzi MG; Carter WB; Shimizu T; Heath H; Moskowitz MA
    Neuropharmacology; 1991 Nov; 30(11):1193-200. PubMed ID: 1663596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of a serotonin agonist (sumatriptan) on the peptidergic innervation of the rat cerebral dura mater and on the expression of c-fos in the caudal trigeminal nucleus in an experimental migraine model.
    Knyihár-Csillik E; Tajti J; Samsam M; Sáry G; Slezák S; Vécsei L
    J Neurosci Res; 1997 Jun; 48(5):449-64. PubMed ID: 9185668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma protein extravasation induced in the rat dura mater by stimulation of the parasympathetic sphenopalatine ganglion.
    Delépine L; Aubineau P
    Exp Neurol; 1997 Oct; 147(2):389-400. PubMed ID: 9344563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The pathophysiology of migraine: a tentative synthesis.
    Lance JW
    Pathol Biol (Paris); 1992 Apr; 40(4):355-60. PubMed ID: 1379708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective inhibition of 5-HT7 receptor reduces CGRP release in an experimental model for migraine.
    Wang X; Fang Y; Liang J; Yin Z; Miao J; Luo N
    Headache; 2010 Apr; 50(4):579-87. PubMed ID: 20236348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurogenic inflammation in the pathophysiology and treatment of migraine.
    Moskowitz MA
    Neurology; 1993 Jun; 43(6 Suppl 3):S16-20. PubMed ID: 8389008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of more and less lipophilic serotonin (5HT1B/1D) agonists in a model of trigeminovascular nociception in cat.
    Hoskin KL; Goadsby PJ
    Exp Neurol; 1998 Mar; 150(1):45-51. PubMed ID: 9514827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Salivary levels of CGRP and VIP in rhinosinusitis and migraine patients.
    Bellamy JL; Cady RK; Durham PL
    Headache; 2006 Jan; 46(1):24-33. PubMed ID: 16412148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Improper equalization of sumatriptan with ergotamine and dihydroergotamine in the Drug Equivalency System].
    Ferrari MD; Haan J; Bax WA; van Coevorden RS; Timmerman H; Meijler WJ
    Ned Tijdschr Geneeskd; 1993 Apr; 137(17):846-50. PubMed ID: 8387648
    [No Abstract]   [Full Text] [Related]  

  • 18. Serotonin receptors and headache.
    Raskin NH
    N Engl J Med; 1991 Aug; 325(5):353-4. PubMed ID: 1647497
    [No Abstract]   [Full Text] [Related]  

  • 19. Colocalization of CGRP with 5-HT1B/1D receptors and substance P in trigeminal ganglion neurons in rats.
    Ma QP; Hill R; Sirinathsinghji D
    Eur J Neurosci; 2001 Jun; 13(11):2099-104. PubMed ID: 11422450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Serotonin agonists and antagonists in migraine].
    Ollat H
    Pathol Biol (Paris); 1992 Apr; 40(4):389-96. PubMed ID: 1353874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.